Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Sporidin-G: GGEN placed a Phase II/III trial

GalaGen Inc. (GGEN), Arden Hills, Minn.
Product:

Read the full 73 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE